Edition:
United Kingdom

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

246.00CHF
4:31pm GMT
Change (% chg)

CHF-0.90 (-0.36%)
Prev Close
CHF246.90
Open
CHF247.40
Day's High
CHF248.00
Day's Low
CHF243.00
Volume
448,064
Avg. Vol
359,858
52-wk High
CHF278.40
52-wk Low
CHF164.23

Select another date:

Wed, Feb 14 2018

BRIEF-Lonza To Establish Cell- And Gene-Therapy Centers Of Excellence

* LONZA TO ESTABLISH CELL- AND GENE-THERAPY CENTERS OF EXCELLENCE TO ACCELERATE GROWTH Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Lonza ‍expands offerings for early phase biopharmaceutical drug development​

* Says ‍expands service offerings for early phase biopharmaceutical drug development​ Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

Lonza buys U.S. clinical manufacturing site from Shire

ZURICH Lonza Group is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire PLC, the Swiss pharmaceutical ingredients group said on Tuesday without giving the purchase price.

Lonza buys U.S. clinical manufacturing site from Shire

ZURICH, Oct 3 Lonza Group is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire PLC, the Swiss pharmaceutical ingredients group said on Tuesday without giving the purchase price.

Select another date: